Haqq Christopher

Insider Buys Quantity –
0
2019-02-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0016%
$39.59$30,682-61.38%
2019-02-11SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,975
0.0302%
$38.55$538,736-58.97%
2019-02-06SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,375
0.0269%
$38.62$477,922-58.44%
2018-11-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0017%
$33.81$26,203-33.08%
2018-09-26SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,500
0.0304%
$43.08$581,580-18.65%
2018-09-25SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,500
0.0277%
$40.51$546,905-21.2%
2018-09-24SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
18,000
0.0389%
$39.91$718,425-15.65%
2018-08-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0018%
$37.54$29,094-0.33%
2018-05-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
25,775
0.0573%
$45.30$1.17M-16.67%
2018-03-26SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
18,327
0.0448%
$39.79$729,265-5.35%
2017-11-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
1,604
0.0051%
$13.36$21,429+177.5%
2017-10-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0198%
$14.35$86,100+167.01%
2017-09-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0192%
$15.30$91,800+141.53%
2017-08-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
7,604
0.0258%
$14.75$112,159+157.89%
2017-07-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0187%
$14.92$89,520+77.14%
2017-06-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0211%
$12.65$75,900+31.5%
2017-05-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
15,208
0.0508%
$14.99$227,968+0.33%
2017-04-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,000
0.0401%
$17.28$207,360-13.84%
2017-03-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,000
0.0429%
$19.60$235,200-19.1%
2017-02-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
15,208
0.0504%
$15.49$235,572-5.28%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us